CircRNAs modulate response of cancer cells to gemcitabine
As a chemotherapeutic agent, gemcitabine makes the backbone of several chemotherapeutic regimens, particularly those used for advanced cancers. However, drug resistance confines the long-term therapeutic impact of gemcitabine in cancer treatment and makes the patients' prognosis poor. Several m...
Saved in:
Main Authors: | Zahra Tajik, Soudeh Ghafouri-Fard |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-12-01
|
Series: | Advances in Cancer Biology - Metastasis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2667394025000115 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Candidate circRNAs related to skeletal muscle development in Dazu black goats
by: Chengli Liu, et al.
Published: (2024-12-01) -
Impact of non-coding RNAs on resistance to imatinib in chronic myelogenous leukemia
by: Fatemeh Ensafi Talemi, et al.
Published: (2025-01-01) -
Geometry-enhanced graph neural networks accelerate circRNA therapeutic target discovery
by: Zhen Li, et al.
Published: (2025-07-01) -
Decoding circRNA translation: challenges and advances in computational method development
by: Jingjing Zhang, et al.
Published: (2025-07-01) -
Impact of Heat Stress on Ovarian Function and circRNA Expression in Hu Sheep
by: Jianwei Zou, et al.
Published: (2025-07-01)